According to Hong Kong Stock Exchange documents, Tianchen Biopharmaceutical (Suzhou) Co., Ltd.-B has passed the Hong Kong Stock Exchange listing hearing.
2026-05-21
According to Hong Kong Stock Exchange documents, Tianchen Biopharmaceutical (Suzhou) Co., Ltd.-B has passed the Hong Kong Stock Exchange listing hearing.